|
[1] H. Hug, T.F. Sarre. 1993. Protein kinase C isoenzymes: divergence in signal transduction? Biochem. J. 291:329–343. [2] Y. Nishizuka. 1995. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9:484–496. [3] E.C. Dempsey, A.C. Newton, D. Mochly-Rosen, A.P. Fields, M.E. Reyland, P.A. Insel, R.O. Messing. 2000. Protein kinase C isozymes and the regulation of diverse cell responses. Am. J. Physiol.: Lung Cell. Mol. Physiol. 279:429–438. [4] A.C. Newton,. 2001. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem. Rev. 101:2353–23564. [5] L.M. Neri, P. Borgatti, S. Capitani, A.M. Martelli. 1998. Nuclear diacylglycerol produced by phosphoinositide-specific phospholipase C is responsible for nuclear translocation of protein kinase C-α.J. Biol. Chem. 273:29738–297344. [6] A.M. Martelli, N. Sang, P. Borgatti, S. Capitani, L.M. Neri. 1999. Multiple biological responses activated by nuclear protein kinase C. J. Cell. Biochem. 74:499–521. [7] Gao QY, Ge J, Wang ZC, Chen HY, Huang DP, Yuan ZH. 2005. The effect of protein kinase C alpha on expression of developmental genes during differentiation of mouse embryonic stem cells into neuron-like cells in vitro. Zhonghua Yan Ke Za Zhi. 41:123-7. [8] Balasubramanian N, Advani SH, Zingde SM. 2002. Protein kinase C isoforms in normal and leukemic neutrophils: altered levels in leukemic neutrophils and changes during myeloid maturation in chronic myeloid leukemia. Leuk Res. 26(1):67-81. [9] Huda R, Vergara LA, Solanki DR, SherwoodER, MathruM. 2004. Selective activation of protein kinase C delta in human neutrophils following ischemia reperfusion of skeletal muscle. Shock. 21(6):500-504. [10] Steinhart R, Kazimirsky G, Okhrimenko H, Ben-Hur T, Brodie C,.2007 PKCepsilon induces astrocytic differentiation of multipotential neural precursor cells. Glia. 55(2):224-232. [11] Lampasso JD, Chen W, Marzec N. 2006. The expression profile of PKC isoforms during MC3T3-E1 differentiation. Int J Mol Med. 217(6): 1125-31. [12] Matsumura M, Tanaka N, Kuroki T, Ichihashi M, Ohba M. 2003.The eta isoform of protein kinase C inhibits UV-induced activation of caspase-3 in normal human keratinocytes. Biochem Biophys Res Commun. 303(1):350-6. [13] Verma AK, Wheeler DL, Aziz MH, Manoharan H. 2006. Protein kinase Cepsilon and development of squamous cell carcinoma, the nonmelanoma human skin cancer. Mol Carcinog. 45(6):381-8. [14] Zhu YY, Wang HM, Kong CZ, Liu DH, Li ZL, Sun ZX, Liu GF. 2005.The role of protein kinase C alpha in recurrence of superficial bladder carcinoma. onghua Wai Ke Za Zhi. 43(10):662-6. [15] Kong C, Zhu Y, Liu D, Yu M, Li S, Li Z, Sun Z, Liu G. 2005. Role of protein kinase C-alpha in superficial bladder carcinoma recurrence. Urology. 65(6):1228-32. [16] Saijoh Y, Fujii H, Meno C, et al. 1996. Identification of putative downstream genes of Oct-3, a pluripotent cell-specific transcription factor. Genes Cells. 1:239-52. [17] Okamoto K, Okazawa H, Okuda A, Sakai M, Muramatsu M, Hamada H . 1990. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell.60:461-72. [18] Niwa, H., Miyazaki, J. & Smith, A. G. 2000. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 24:372-6. [19] Kuroda T, Tada M, Kubota H, et al. 2005. Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol Cell Biol 25:2475-85. [20] Chambers I, Colby D, Robertson M, et al. 2003. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell.113: 643-55. [21] Pan G, Pei D. 2005. The stem cell pluripotency factor NANOG activates transcription with two unusually potent subdomains at its C terminus. J Biol Chem. 280:1401-7. [22] Kuroda T, Tada M, Kubota H, et al. 2005. Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol Cell Biol. 25(6):2475-85. [23] Lin, T., Chao, C., Saito, S., Mazur, S. J., Murphy, M. E., Appella, E., and Xu,Y. 2005. Mol Cell Biol. 7:165–171. [24] Storm MP, Bone HK, Beck CG, Bourillot PY, Schreiber V, Damiano T, Nelson A, Savatier P, Welham MJ. 2007. Regulation of Nanog Expression by Phosphoinositide 3-Kinase-dependent Signaling in Murine Embryonic Stem Cells. J. Biol. Chem. 282:6265–6273. [25] Sato, N., Meijer, L., Skaltsounis, L., Greengard, P., and Brivanlou, A. H. 2004.Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 10:55–63. [26] Hamazaki T, Kehoe SM, Nakano T, Terada N. 2006.The Grb2/Mek pathway represses Nanog in murine embryonic stem cells. Mol Cell Biol. 26(20):7539-49. [27] Ezeh UI, Turek PJ, Reijo RA, Clark AT. 2005.Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma.Cancer. 104(10):2255-65. [28] Hart AH, Hartley L, Parker K, Ibrahim M, Looijenga LH, Pauchnik M, Chow CW, Robb L. 2005.The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer. 104(10):2092-8. [29] Zhang J, Wang X, Li M, Han J, Chen B, Wang B,DaiJ. 2006.NANOGP8 is a retrogene expressed in cancers. FEBS J. 273(8): 1723-30. [30] Chong VF, Ong CK.2008. Nasopharyngeal carcinoma. Eur J Radiol. 66(3): 437-47. [31] David J. Rodda, Joon-Lin Chew, Paul Robson.2005.Transcriptional Regulation of Nanog by OCT4 and SOX2. The journal of biological chemistry. 280(26): 24731-37. [32] Takao Kuroda,1 Masako Tada,1,2 Hiroshi Kubota. 2005. Octamer and Sox Elements Are Required for Transcriptional cis Regulation of Nanog Gene Expression. Molecular and cellular biology. 25(6): 2475-85. [33] Porter M.J., Field j.k., Lee J.C., Leung S.F., Lo D. 1994. Detection of the tumor suppressor gene p53 in Nasopharyngeal carcinoma in Hong Kong Chinese . Anticancer Reseach. 14: 1359-60. [34] Constantinescu D., Gray, H.L., Sammak,P.J., Schatten,G.P., Csoka,A.B.2006.Lamin A/C expression is a maker of mouse and human embryonic stem cell differentiation. Stem Cells 24: 177-185. [35] Chiou S.H., Yu C.C., Huang C.Y., Lin S.C., Liu C.J., Tsai T.H., Chou S.H., Chien C.S., Ku H.H..2008.Positive correlations of oct-4 and nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Stem Cells. 14(13): 4085-95.
|